[PDF] Top 20 CTLA4 blockade increases Th17 cells in patients with metastatic melanoma
Has 10000 "CTLA4 blockade increases Th17 cells in patients with metastatic melanoma" found on our website. Below are the top 20 most common "CTLA4 blockade increases Th17 cells in patients with metastatic melanoma".
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma
... by CTLA4 blocking ...and Th17 mediated by IL-2 [30], suggesting that their effects may be mutually exclusive as opposed to ...that CTLA4 is expressed on murine Th17 cells at lev- els ... See full document
13
Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma.
... microarray based techniques, as well as xenografting studies. In the present study we have adapted the negative cell separation strategy for the analysis of CMCs from blood samples donated by patients with ... See full document
12
Toxicity management of immunotherapy for patients with metastatic melanoma
... of patients with metastatic melanoma offering improved responses and significant survival ...of metastatic melanoma, squamous and non-squamous non-small cell lung cancer (NSCLC) and ... See full document
11
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail pulsed dendritic cells
... on metastatic melanoma patients with HLA-A2 or A24 ...of metastatic melanoma were enrolled into a phase I study using HLA-A2 or A24-restricted peptide cocktail- pulsed ...2 ... See full document
10
The Pattern and Cost of Palliative Surgeries in Patients with Metastatic Melanoma
... in patients with metastatic melanoma in the ...of patients identified using administrative claims from MarketScan ® databases among patients with metas- tatic melanoma diagnosed ... See full document
6
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
... for metastatic melanoma patients must also be considered as evident by our finding that under- insured patients with Medicaid insurance or no insur- ance had a much higher probability of being ... See full document
11
Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
... in patients with metastatic melanoma stage IV, including overall survival and progression-free ...survival. Patients with elevated serum sCD73 enzyme activity had a significantly increased ... See full document
9
Medical Costs by Disease Stage in Medicare Patients with Metastatic Melanoma
... ers, melanoma-specific costs, and adjust for confounding factors across disease stages will help better understand the disease specific ...for metastatic melanoma has been changing as some new ... See full document
11
Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients
... checkpoint blockade with monoclonal anti- bodies against cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1) or their ligands, such as PD1 ligand 1 (PD-L1) has revo- lutionized the ... See full document
10
Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device
... Tumour Cells (CTCs) are promising cancer ...of melanoma CTCs is very challenging as a result of their extraordinary heterogeneity, which has hindered their biological and clinical ...isolate melanoma ... See full document
15
Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma
... for metastatic melanoma with BRAF V600 ...noncutaneous melanoma, including acral and mucosal subtypes, the efficacy of BRAF inhibitors for this subset of patients has not been extensively ... See full document
8
Adenovirus mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
... Conclusions In conclusion, we report that the adenovirus-mediated CD40L gene transfer consistently increased the Teff/Treg ratio in the PBMCs while the fold induction of gMDSCs correlated inversely to survival. In ... See full document
11
Clinical effects of stereotactic radiation surgery in patients with metastatic melanoma
... INTRODUCTION Melanoma has high metastatic ...in melanoma and induces disturbance of the central nervous system, which consequently prevents communication between the patient and the family in the ... See full document
15
Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review
... additional patients treated with the combination of cra- nial radiation and ipilimumab (Table ...include patients initially treated with ...between patients that received SRS prior or after ... See full document
6
Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review
... additional patients treated with the combination of cra- nial radiation and ipilimumab (Table ...include patients initially treated with ...between patients that received SRS prior or after ... See full document
7
Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma
... some patients [29], whereas another study (n = 10) reported a small significant increase in Treg follow- ing tremelimumab ...all patients or compared to non-relapsed and relapsed patients (Table ... See full document
11
Lethal aplastic anemia caused by dual immune checkpoint blockade in metastatic melanoma.
... in patients with metastatic melanoma, however the combination therapy increases the risk of immune-related adverse events, in particular diarrhea/colitis, hepatitis, pruritus/rash and ... See full document
7
Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series.
... combination treatment early due to toxicity, 81 (68%) experienced a complete or partial response [ 4 ]. The median duration of response in this group who discontinued early was 13 months, comparable with the overall ... See full document
12
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
... for patients with advanced solid tumors, which included multiple melanoma expan- sion ...655 melanoma patients enrolled (135 from a nonrandomized cohort [n = 87 ipilimumab naive; n = 48 ... See full document
10
IGFBP-3 inhibits Wnt signaling in metastatic melanoma cells.
... of patients with diffuse metastatic ...cultured metastatic melanoma cells and to prevent growth of grafted melanomas in ...cultured cells or live mice, it might qualify as an ... See full document
13
Related subjects